中安科股份有限公司关于回购注销部分限制性股票的公告

Core Viewpoint - The company has announced the repurchase and cancellation of 3,481,750 restricted shares due to the departure of nine incentive recipients who no longer qualify for the incentive program [2][14][18]. Group 1: Repurchase Details - The number of restricted shares to be repurchased is 3,481,750 shares [2]. - The repurchase price is set at the grant price of 1.25 yuan per share, totaling approximately 4,352,187.50 yuan [15]. - The funding for the repurchase will come entirely from the company's own funds [16]. Group 2: Approval Process - The repurchase has been authorized by the company's shareholders at the 2023 first extraordinary general meeting held on April 3, 2023 [4][18]. - The board of directors approved the repurchase at the 12th board meeting on August 12, 2025, without needing further shareholder approval [2][38]. Group 3: Impact on Share Capital - Following the repurchase, the total number of shares will decrease from 2,876,607,560 shares to 2,866,180,886 shares [18]. - The repurchase will not have a substantial impact on the company's financial status or operational results [19][22]. Group 4: Compliance and Legal Opinions - The repurchase complies with relevant laws, regulations, and the company's incentive plan [21][22]. - Legal opinions confirm that the necessary approvals and procedures have been followed for the repurchase [22].